External broker reports(aggregated public sources), Axis Direct

Axis Direct

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only.  Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

External broker reports(aggregated public sources)

Axis Direct is the flagship brand under Axis Securities Limited, a subsidiary of Axis Bank in India. 

Content available is external broker reports authored by a third party outside the Smartkarma network and has been aggregated by an online aggregator through publicly available sources and is displayed by Smartkarma in this format for user's convenience and general informational purposes only. Content does not constitute investment or financial advice and Smartkarma makes no representation or warranty regarding its accuracy or contents. Original third party author retains all copyright and other proprietary rights in the content. Access or use of third party links not controlled by Smartkarma are at the user's own risk.

Equity Bottom-Up

<ul><li>Blends business is expected to remain resilient: CFS North America, CFS Mexico and CFS Brazil are subsidiaries which predominantly sells blend, continue their growth momentum as top lines build and operational leverage leads to improved profitability.</li><li>CFS North America topline grew to Rs. 255.2 cr in FY24 vs 85 Cr in FY23. Company expects CFS North America business to grow at ~25% in FY25.</li><li>Expect similar strong momentum in other these American subsidiaries with profitability maintained in blends business.</li></ul><p><em>Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.</em></p>

Blends business is expected to remain resilient: CFS North America, CFS Mexico and CFS Brazil are subsidiaries which predominantly sells blend, continue their growth momentum as top lines build and operational leverage leads to improved profitability.CFS North America topline grew to Rs. 255.2 cr in FY24 vs 85 Cr in FY23. Company expects CFS North America business to grow at ~25% in FY25.Expect similar strong momentum in other these American subsidiaries with profitability maintained in blends business.Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only. Refer full disclaimer below.

Camlin Fine Sciences Ltd - Price Slump Leads to Inventory Write-Offs